MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Ethnic differences in rates of Parkinson’s in New Zealand: A nation-wide prevalence and incidence study

T.L. Pitcher, D.J. Myall, M.R. MacAskill, J.F. Pearson, C.J. Lacey, J.C. Dalrymple-Alford, T.J. Anderson (Christchurch, New Zealand)

Meeting: 2016 International Congress

Abstract Number: 463

Keywords: Parkinsonism

Session Information

Date: Monday, June 20, 2016

Session Title: Epidemiology

Session Time: 12:30pm-2:00pm

Location: Exhibit Hall located in Hall B, Level 2

Objective: To estimate the prevalence and incidence of Parkinson’s in New Zealand and to investigate if these measures differ between the major ethnic groups represented in the New Zealand population.

Background: New Zealand is a culturally diverse island nation located in the South Pacific Ocean. The resident population at the 2013 census was 4.2 million people. The major ethnic groups are European, Maori, Asian, and Pacific. No previous studies have used nation-wide data to estimate prevalence and incidence of Parkinson’s in New Zealand.

Methods: Information on Parkinson’s-related medications was extracted from the national pharmaceutical database of community-dispensed medications for the period 1 January 2005 to 31 December 2014 for all of New Zealand. Drug-tracing methods were used to establish the likelihood of a Parkinson’s diagnosis for those over 20 years of age. Each individual was classified into one of four categories (very probable, probable, possible, and unlikely) based on their medication use for the entire period they appeared in the dataset. Diagnosis confirmation for a sub-set of people was achieved through national mortality and hospital admissions databases, as well as local research and neurological outpatient databases. Prevalence and incidence rates were calculated for 2013 using Statistics New Zealand data, and were age-standardized using the New Zealand 2013 population age profile.

Results: The 2013 national prevalence of Parkinson’s in New Zealand was 217 per 100,000 population. We saw higher age-standardized prevalence rates for males compared to females (272 vs. 170 per 100,000, ratio 1.64:1). Incidence was 32 per 100,000 person-years, with age-standardized rates higher in males (40 vs. 23 per 100,000 person-years, ratio 1.7:1). Prevalence and incidence were higher in the European ethnic group compared to other ethnicities. Age-standardized rates – prevalence; European: 245, Asian: 185, Pacific: 162, and Maori: 104: per 100,000 population and incidence; European: 38, Asian: 30, Pacific: 26, and Maori: 22 per 100,000 person-years, respectively.

Conclusions: We found differing rates of Parkinson’s across ethnicities even after accounting for relative population age profiles. Varying genetic and environmental influences, as well as differing healthcare access rates, are potential explanations for these observed ethnic differences.

To cite this abstract in AMA style:

T.L. Pitcher, D.J. Myall, M.R. MacAskill, J.F. Pearson, C.J. Lacey, J.C. Dalrymple-Alford, T.J. Anderson. Ethnic differences in rates of Parkinson’s in New Zealand: A nation-wide prevalence and incidence study [abstract]. Mov Disord. 2016; 31 (suppl 2). https://www.mdsabstracts.org/abstract/ethnic-differences-in-rates-of-parkinsons-in-new-zealand-a-nation-wide-prevalence-and-incidence-study/. Accessed June 14, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2016 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/ethnic-differences-in-rates-of-parkinsons-in-new-zealand-a-nation-wide-prevalence-and-incidence-study/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley